Entertainment
Taylor Swift and Scooter Braun’s Bad Blood: A Complete Timeline on August 23, 2023 at 9:21 pm Us Weekly

The bad blood between Taylor Swift and Scooter Braun has inspired song lyrics, forced celebrities to take sides and incurred the wrath of Swifties.
The drama came to a head in June 2019 when it was announced that Braun’s media company, Ithaca Holdings, had acquired Scott Borchetta’s Big Machine Label Group for $300 million. Through the deal, Braun became the new owner of Swift’s first six albums with Big Machine Records: her self-titled debut, Fearless, Speak Now, Red, 1989 and Reputation.
Swift condemned the business deal via Tumblr, calling it her “worst case scenario” and claiming that she’d faced “incessant, manipulative bullying” from Braun for years.
That August, the singer announced her plans to rerecord her first six albums in an attempt to regain the rights to her masters. “I think artists deserve to own their own work,” she told Robin Roberts during an appearance on Good Morning America.
Keep scrolling for a complete timeline of Swift and Braun’s feud:
Justin’s ‘Taylor Swift What Up’ Post (August 2016)
Justin Bieber shared a since-deleted photo via Instagram of him FaceTiming Braun and Kanye West, who was then a client of Braun’s. “Taylor Swift what up,” he captioned the snap. The post came amid Swift’s infamous feud with West.
Taylor’s Tumblr Post (July 2019)
After Braun’s acquisition of Big Machine made headlines in July 2019, Swift slammed the business deal via Tumblr.
In the lengthy blog post, the musician claimed that “for years,” she’d “pleaded for a chance to own my work” but was instead “given an opportunity to sign back up to Big machine Records and ‘earn’ one album back at a time, one for every new one I turned in.”
Swift, who became Big Machine’s first client in 2005, continued: “I walked away because I knew once I signed that contract, [Big Machine Records founder and CEO] Scott Borchetta would sell the label, thereby selling me and my future. I had to make the excruciating choice to leave behind my past.”
The 12-time Grammy winner then claimed that she found out Braun had purchased her masters after the deal was made public. “All I could think about was the incessant, manipulative bullying I’ve received at his hands for years,” she wrote. “Now Scooter has stripped me of my life’s work, that I wasn’t given an opportunity to buy. Essentially, my musical legacy is about to lie in the hands of someone who tried to dismantle it. This is my worst case scenario.”
Swift also included a screenshot of Bieber’s infamous “Taylor Swift what up” Instagram post, writing, “This is Scooter Braun, bullying me on social media when I was at my lowest point.”
That same month, Bieber apologized for the post via Instagram saying that it was “distasteful and insensitive.” He also defended Braun, claiming that the music executive “didn’t have anything to do with” the post. “In all actuality he was the person who told me not to joke like that,” Bieber wrote.
Taylor Asks Fans for Help (November 2019)
Swift shared an update on the feud and directly asked her fans for help. In a letter shared via Twitter, she claimed that Borchetta and Braun told her she wasn’t allowed to perform any music from her first six albums during her American Music Awards performance.
Taylor Swift and Scooter Braun. Getty Images
“I’ve been planning to perform a medley of my hits throughout the decade on the show,” she wrote of the then-upcoming performance.. “The message being sent to me is very clear. Basically, ‘Be a good little girl and shut up. Or you’ll be punished.’”
Swift then asked fans to reach out to celebrities who work with Braun in hopes that they could help her get permission to play her songs.
“Scooter also manages several artists who I really believe care about other artists and their work,” she penned. “Please ask them for help with this — I’m hoping that maybe they can talk some sense into the men who are exercising tyrannical control over someone who just wants to play the music she wrote.”
Later that month, Big Machine denied Swift’s claims in a lengthy statement. “At no point did we say Taylor could not perform on the AMAs,” the label claimed. “In fact, we do not have the right to keep her from performing live anywhere.”
Scooter Sells Taylor’s Masters (November 2020)
Less than a year and a half after acquiring them, Braun sold Swift’s master rights to Shamrock Holdings for over $300 million. That same month, Swift shut down rumors that she’d purchased her catalog from Braun, revealing that the sale had occurred without her knowledge.
“He would never even quote my team a price. These master recordings were not for sale to me,” she claimed via Twitter.
The Taylor’s Version Era Begins (April 2021)
Swift made good on her promise to rerecord her first six albums and released Fearless (Taylor’s Version) in April 2021.
“I’ve spoken a lot about why I’m remaking my first six albums but the way I’ve chosen to do this will hopefully help illuminate where I’m coming from,” she wrote in the album’s prologue letter. “Artists should own their own work for so many reasons, but the most screamingly obvious one is that the artist is the only one who really knows that body of work.”
Taylor Swift and Scooter Braun. Getty Images
Swift went on to release Red (Taylor’s Version) in November 2021 and Speak Now (Taylor’s Version) in July 2023. In August 2023, she announced that 1989 (Taylor’s Version) will be released in October 2023.
Scooter Speaks Out (June 2021)
Braun shared his side of the story during an interview for a Variety cover story. “I regret and it makes me sad that Taylor had that reaction to the deal,” he told the outlet, claiming that the details Swift shared about the acquisition were “not based on anything factual.”
He continued: “I don’t know what story she was told. I asked for her to sit down with me several times, but she refused.”
Braun added that he was most hurt by Swift’s characterization of him as a bully. “I’m firmly against anyone ever being bullied. I always try to lead with appreciation and understanding. The one thing I’m proudest of in that moment was that my artists and team stood by me. They know my character and my truth. That meant a lot to me,” he said.
Scooter Loses Clients (August 2023)
Demi Lovato, who previously defended Braun in July 2019 when Swift called him out for bullying, was one of several high-profile clients to reportedly cut ties with Braun in August 2023 along with Ariana Grande and Bieber.
An insider with knowledge of the situation told Us at the time that “all of Scooter Braun’s clients are under contract and negotiations have been going on for several months as Scooter steps into his larger role as Hybe America CEO.”
Swift’s fans were quick to theorize that the reports were indicative of trouble ahead for Braun. “How Taylor Swift is sleeping knowing Scooter Braun’s empire is crumbling #karma,” one Twitter user wrote alongside a photo of the titular mouse from Tom and Jerry snoozing soundly in a bed.
Another chimed in: “Justin Bieber, Demi Lovato and Ariana Grande leaving Scooter Braun?????!!?!?! Oh honey, this is better than revenge,” referencing Swift’s 2010 track of the same name.
The bad blood between Taylor Swift and Scooter Braun has inspired song lyrics, forced celebrities to take sides and incurred the wrath of Swifties. The drama came to a head in June 2019 when it was announced that Braun’s media company, Ithaca Holdings, had acquired Scott Borchetta’s Big Machine Label Group for $300 million. Through
Us Weekly Read More
Advice
Independent Film’s New Reality: 10 Brutal Truths You Have to Face in 2026

If you are still approaching independent film like it’s 2015, you are going to get crushed. The landscape that once rewarded a scrappy feature and a couple of festival laurels has become a crowded, algorithm‑driven marketplace where attention is the rarest currency. Recent industry analysis on “inflection points” for 2026 all say the same thing: the business model for independent film has changed, whether you like it or not.

1. You’re Competing With Everything
Your film is no longer just competing with other indie features. It is fighting for attention against TikTok clips, prestige series, and endless back catalog on every streaming platform. That means “pretty good” is invisible. You either have a sharp, specific audience and a clean logline, or you disappear into the scroll.
2. Festivals Are Not a Distribution Plan
A festival premiere and a few Q&As can help with credibility, but they are not a business strategy. Without a parallel plan—email list, community building, partnerships, and a clear path to paid viewers—you come home with a laurel and no deal. Even festival‑aligned organizations now frame their “don’t miss indies” coverage as part of a broader visibility and audience strategy, not a finish line.
3. The Middle Is Collapsing
Industry voices are blunt about it: micro‑budget genre films and clearly branded auteur work still find lanes, but the soft, mid‑budget drama with no hook is almost impossible to monetize. If your film cannot be pitched in one or two sentences to a specific audience, it will struggle regardless of how “good” it is.
4. You Are a Small Business, Not a Starving Artist
The indie filmmakers who will survive 2026 are treating their careers like businesses. Guides focused on creating a “film business turnaround” talk about lifetime value, repeat customers, multiple revenue streams, and audience retention—not just finishing one feature. Your filmography is a product line, not a lottery ticket.
5. SAG Is a Competitive Advantage
SAG actors and union rules are not your enemy; they are a way to level up. SAGindie and SAG‑AFTRA low‑budget agreements exist to help genuine independents hire professional talent and present themselves as serious, compliant productions. Understanding those tools gives you access to stronger cast, better reputations, and more credible pitches.
6. Streaming Is Not a Golden Ticket
Streaming is no longer the dream “one deal solves everything” outcome. The deals are leaner, the competition is brutal, and many filmmakers now make more by going direct‑to‑fan through TVOD, memberships, or niche platforms than by chasing a low‑MG all‑rights license. You need to know why you want a streamer—brand value, audience reach, or pure revenue—and plan accordingly.
7. Format Matters Less Than Relationship
Audiences care more about access than whether your project is a feature, series, or hybrid. If you give them a reason to show up repeatedly, they will follow you across formats. If you do not, a 90‑minute feature is just one more piece of content in an endless feed.elliotgrove.
8. Marketing Starts at Concept
Marketing is not something you “figure out later.” The most effective 2026 indies build their hook at the idea stage—title, poster, and logline are treated as core creative decisions, not afterthoughts. If you cannot imagine the trailer, one‑sheet, and social teaser while you are still outlining, that is a red flag.

9. Community Is Your Real Safety Net
Filmmakers who plug into networks, reading lists, and producer education hubs are adapting the fastest. They are not reinventing the wheel alone; they are leveraging shared knowledge, updated contracts, and peer feedback to make smarter decisions project by project.
10. Accepting Reality Is Your Edge
Here is the real brutal truth: if you can accept all of this, you gain an edge. Most of the field is still clinging to old myths about discovery, “overnight” success, and festival miracles. If you are willing to treat your indie career as a living, evolving business—grounded in current data and audience behavior—2026 might be the moment where “truly independent” stops meaning powerless and starts meaning in control.
Entertainment
Ozempic Era: Beauty, Lizard Venom, Big Pharma

The film industry is entering a new body era, and this time, the co-star is a syringe.
GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have moved from diabetes clinics into casting conversations, red carpets, and agency strategy. In the United States, roughly 1 in 8 adults report having used a GLP-1 drug, with about 6 to 12 percent actively using one today. Globally, usage has surged from approximately 4 million people in 2020 to around 30 million by 2026.
This is no longer a niche health trend. It is a structural shift—one that is reshaping how bodies are constructed, perceived, and rewarded on screen.

At a clinical level, the appeal is clear. In major obesity trials, semaglutide has produced average weight loss of 15 to 17 percent of total body weight over 68 to 104 weeks, with some regimens approaching 19 to 21 percent for sustained users. In an industry built on transformation, those numbers carry real influence.
But rapid transformation leaves a visible trace. The phenomenon often called “Ozempic face”—hollowed cheeks, looser skin, a subtly aged appearance—reflects how quickly fat loss can outpace the skin’s ability to adjust.
For filmmakers, this is not just aesthetic—it is cinematic. Performance lives in the face. Micro-expressions, softness, and facial volume shape how emotion reads on camera. A performer may reach an “ideal” body while losing something less measurable but equally important on screen.
Beneath this cultural shift lies an origin story that feels almost written for film.
In the 1990s, researchers studying the Gila monster isolated a peptide in its venom called exendin-4, which mimicked a human hormone involved in blood sugar regulation but lasted significantly longer in the body. That discovery led to early GLP-1 drugs such as exenatide, used by millions of patients worldwide, and eventually to semaglutide.
By mid-2025, semaglutide-based drugs (including Ozempic and Wegovy) generated approximately $16 to $17 billion in just six months, making it one of the highest-grossing drug classes globally. Analysts project the broader incretin market could reach $200 billion annually by 2030.
Inside those numbers is a more complex human story.
The benefits are well documented: improved blood sugar control, significant weight loss, and reduced cardiovascular risk. But as use expands, so does scrutiny. Researchers and regulators are tracking side effects ranging from severe gastrointestinal issues and gastroparesis to gallbladder disease and pancreatitis, as well as rarer concerns such as vision complications and potential neurological signals.
At the same time, adoption continues to accelerate. J.P. Morgan projects roughly 10 million Americans on GLP-1 drugs by 2025, rising toward 25 to 30 million by 2030. At that scale, usage becomes ambient—part of everyday life across industries, including film and television.
And yet the marketing tells a different story. Pharmaceutical campaigns rely on cinematic language—aspirational visuals, controlled lighting, emotional transformation arcs—while legally required risk disclosures recede into fine print.
For independent filmmakers, this moment opens several narrative lanes.
There is the body: performers navigating an industry where a once-niche diabetes drug has become a quiet career tool.
There is the machine: a pharmaceutical ecosystem where a single drug category generates tens of billions annually, rivaling major entertainment sectors.
And there is the myth: a culture increasingly turning to a hormone-based intervention—derived from venom biology—rather than addressing systemic issues like food access, stress, and inequality.
Technology intensifies all of it. Ultra-high-resolution cameras and HDR workflows capture every detail—skin texture, volume shifts, micro-expressions. As more on-screen talent uses the same class of drugs, a new visual baseline begins to form, often without audiences realizing why.
There is also a clear economic divide. GLP-1 drugs can cost $800 to $1,000 or more per month without insurance in the United States, and coverage remains inconsistent. Rising demand has led to shortages and a parallel market of compounded or unregulated alternatives.

The gap between who can access consistent, medically supervised treatment and who cannot is becoming part of the story itself.
For cinema, the imagery is already there: the Sonoran desert, a Gila monster, laboratory research, pharmaceutical earnings calls, red carpets, and transformation narratives.
A compound derived from venom becomes a global product that reshapes not only bodies, but expectations.
Perhaps the most uncomfortable layer is the industry’s own role. Casting preferences, transformation culture, and unspoken aesthetic standards reinforce a pharmacological look without ever naming it.
No one explicitly instructs performers to take these drugs. The system simply rewards the results.
This is not a distant trend. It is a present-tense shift.
The numbers are rising. The images are changing. The influence is expanding.
The question is whether independent cinema will define this moment while it is still unfolding—or whether the story will once again be shaped by the industries profiting most from it.
Advice
How to Find Your Voice as a Filmmaker

Every filmmaker aspires to create projects that are not only memorable but also uniquely their own. Finding your creative voice is a journey that requires self-reflection, bold choices, and an unwavering commitment to your vision. Here’s how to uncover your style, take risks, and craft original work that stands out.
1. Discovering Your Voice: Understanding Your Influences
Your unique voice begins with recognizing what inspires you.
- Step 1: Reflect on the themes, genres, or emotions that consistently draw your interest. Are you inspired by human resilience, surreal worlds, or untold histories?
- Step 2: Study the work of filmmakers you admire. Analyze what resonates with you—their use of color, pacing, or narrative techniques.
Tip: Combine what you love with your personal experiences to create a lens that only you can offer.
Example: Wes Anderson’s whimsical, symmetrical worlds stem from his love of classic storytelling and his unique visual style.
Takeaway: Start with what moves you, then add your personal touch.
2. Taking Creative Risks: Experiment and Evolve
To stand out, you must be willing to challenge conventions and explore new territory.
- Experimentation: Try unusual storytelling structures, such as non-linear timelines or silent sequences.
- Collaboration: Work with people outside your usual circle to gain fresh perspectives.
- Feedback: Screen your projects for trusted peers and be open to constructive criticism.
Example: Jordan Peele blended horror with social commentary in Get Out, creating a genre-defying film that captivated audiences.
Takeaway: Risks are an opportunity for growth, even if they don’t always succeed.
3. Telling Original Stories: Start with Authenticity
Original projects resonate when they stem from a place of truth.
- Draw from Experience: Incorporate elements of your own life, culture, or worldview into your stories.
- Explore the “Why”: Ask yourself why this story matters to you and how it connects with your audience.
- Avoid Trends: Focus on timeless narratives rather than chasing current fads.
Example: Greta Gerwig’s Lady Bird was deeply personal, based on her experiences growing up in Sacramento. The film’s authenticity made it universally relatable.
Takeaway: The more personal the story, the more it resonates.
4. Developing Your Style: Consistency Meets Creativity
Style is not just about visuals—it’s how you tell a story across all elements of filmmaking.
- Visual Language: Experiment with colors, lighting, and framing to create a distinct aesthetic.
- Narrative Voice: Develop consistent themes or motifs across your projects.
- Sound Design: Use music, sound effects, and silence to evoke specific emotions.
Example: Quentin Tarantino’s use of dialogue, pop culture references, and bold music choices makes his work instantly recognizable.
Takeaway: Your style should be intentional, evolving as you grow but always recognizable as yours.
5. Staying True to Yourself: Building Confidence in Your Vision
The filmmaking process is full of challenges, but staying true to your voice is essential.
- Stay Authentic: Trust your instincts, even if your ideas seem unconventional.
- Adapt Without Compromise: Be open to feedback but maintain your core vision.
- Celebrate Your Growth: View every project, successful or not, as a stepping stone in your creative journey.
Example: Ava DuVernay shifted from public relations to filmmaking, staying true to her voice in films like Selma and 13th, which focus on social justice.
Takeaway: Your voice evolves with every project, so embrace the process.
Conclusion: From Idea to Screen, Your Voice is Your Superpower
Finding your voice as a filmmaker takes time, courage, and commitment. By exploring your influences, taking risks, and staying true to your perspective, you’ll craft stories that not only stand out but also resonate deeply with your audience.
Bolanle Media is excited to announce our partnership with The Newbie Film Academy to offer comprehensive courses designed specifically for aspiring screenwriters. Whether you’re just starting out or looking to enhance your skills, our resources will provide you with the tools and knowledge needed to succeed in the competitive world of screenwriting. Join us today to unlock your creative potential and take your first steps toward crafting compelling stories that resonate with audiences. Let’s turn your ideas into impactful scripts together!
Advice2 weeks agoHow to Make Your Indie Film Pay Off Without Losing Half to Distributors
Advice2 weeks agoHow to Find Your Voice as a Filmmaker
Business3 weeks agoWhat the Michael Biopic Means for Every Indie Filmmaker
Business2 weeks agoGLOBAL SUSTAINABILITY SUMMIT RETURNS FOR ITS 5TH EDITION AT THE BRITISH PARLIAMENT – HOUSE OF LORDS, PALACE OF WESTMINSTER
News1 week agoCan AI Really Steal Your Fingerprints From a Selfie?
Film Industry1 week agoActors Win AI Deal – But Your Face Is Still Training the Machine
Business1 week agoBuilding a 10 Million Army: One Leader’s Mission to Save Tomorrow
Entertainment1 week agoOzempic Era: Beauty, Lizard Venom, Big Pharma




















